Ahold Delhaize Agrees to $40M Settlement Over Inflated Prescription Price Reporting
Grocery chain Ahold Delhaize has agreed to a $40 million settlement with federal authorities over allegations of submitting inflated prescription drug pricing data, which led government healthcare programs like Medicare Part D and Medicaid to reimburse pharmacies at higher rates. The issue does not involve consumer checkout prices but affects taxpayer-funded health care spending.